Bessemer Group’s iRadimed IRMD Stock Holding History

Bessemer Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$399K	Buy	4,173 +456	+12%	+$41.5K	﹤0.01%	1230
2026 Q1	$358K	Sell	3,717 -557	-13%	-$55.7K	﹤0.01%	1234
2025 Q4	$416K	Sell	4,274 -50	-1%	-$4.29K	﹤0.01%	1190
2025 Q3	$308K	Sell	4,324 -29	-0.7%	-$1.93K	﹤0.01%	1013
2025 Q2	$260K	Buy	4,353 +58	+1%	+$3.18K	﹤0.01%	1036
2025 Q1	$225K	Buy	4,295 +152	+4%	+$8.54K	﹤0.01%	1052
2024 Q4	$228K	Buy	4,143 +362	+10%	+$19.1K	﹤0.01%	1045
2024 Q3	$190K	Hold	3,781	–	–	﹤0.01%	1130
2024 Q2	$166K	Sell	3,781 -382	-9%	-$16.2K	﹤0.01%	1046
2024 Q1	$183K	Buy	+4,163	New	+$184K	﹤0.01%	1037

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bessemer Group's IRMD Position: Q2 2026 in Review

Bessemer Group increased its iRadimed (IRMD) stake by 12% in Q2 2026, buying an estimated $41.5K and bringing the position to 4,173 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #1230.

Bessemer Group first reported a position in IRMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $416K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Bessemer Group held 4,173 shares of iRadimed worth $399K as of Q2 2026.
Bessemer Group bought 456 iRadimed shares in Q2 2026, an estimated $41.5K.
iRadimed made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1230 holding.
Bessemer Group first reported a position in iRadimed in Q1 2024 and has held it in 10 quarters since.
Bessemer Group's iRadimed position peaked at $416K in Q4 2025.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.